Plain-English translation of NCT06227611 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Glaucoma is an eye disease that can damage your vision by harming the nerve cells in your eye. This study is testing whether different ways of measuring your visual field—the area you can see without moving your eyes—can better detect glaucoma early, especially in patients whose nerve layer is already starting to thin. The researchers want to find the best testing method so doctors can catch glaucoma sooner.
Early detection of glaucoma is critical because catching it before vision loss happens can help prevent blindness. Currently, doctors use different tests to check for glaucoma, but it's not always clear which testing method works best for patients in the early stages. This study aims to find the most accurate approach.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will complete visual field tests using three different testing grids or methods during your visit. Each test measures how well you can see in your peripheral vision. The study involves approximately 16 participants total, and the visits will take place at the research center. Your eye imaging results will also be reviewed to assess your ganglion cell layer thickness.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy
Sponsor
Fondazione G.B. Bietti, IRCCS
Enrollment target
~16 participants
Started
May 2021
Primary completion
May 2022
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.